A number of IDH1 and IDH2 mutations have been reported in glioma, with the most common a base substitution in codon 132 of IDH1 resulting in an arginine to histidine replacement (IDH1R132H) (24, 67). This evidence concerns the gene IDH2 and central nervous system cancer.